68 related articles for article (PubMed ID: 16364256)
1. Selection of ovine PrP high-producer subclones from a transfected epithelial cell line.
Falanga PB; Blom-Potar MC; Bittoun P; Goldberg ME; Hontebeyrie M
Biochem Biophys Res Commun; 2006 Feb; 340(1):309-17. PubMed ID: 16364256
[TBL] [Abstract][Full Text] [Related]
2. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
[TBL] [Abstract][Full Text] [Related]
3. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
4. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
Sakudo A; Wu G; Onodera T; Ikuta K
Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
6. Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies.
Kocisko DA; Caughey B
Methods Enzymol; 2006; 412():223-34. PubMed ID: 17046661
[TBL] [Abstract][Full Text] [Related]
7. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
Filesi I; Cardinale A; Mattei S; Biocca S
J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
[TBL] [Abstract][Full Text] [Related]
8. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
10. Cell culture models to unravel prion protein function and aberrancies in prion diseases.
Bedecs K
Methods Mol Biol; 2008; 459():1-20. PubMed ID: 18576144
[TBL] [Abstract][Full Text] [Related]
11. The stability and aggregation of ovine prion protein associated with classical and atypical scrapie correlates with the ease of unwinding of helix-2.
Fitzmaurice TJ; Burke DF; Hopkins L; Yang S; Yu S; Sy MS; Thackray AM; Bujdoso R
Biochem J; 2008 Jan; 409(2):367-75. PubMed ID: 17931166
[TBL] [Abstract][Full Text] [Related]
12. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
13. Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
Morel N; Andréoletti O; Grassi J; Clément G
Rapid Commun Mass Spectrom; 2007; 21(24):4093-100. PubMed ID: 18008391
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
15. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
16. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
17. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
18. Screening for improved cell performance: selection of subclones with altered production kinetics or improved stability by cell sorting.
Böhm E; Voglauer R; Steinfellner W; Kunert R; Borth N; Katinger H
Biotechnol Bioeng; 2004 Dec; 88(6):699-706. PubMed ID: 15532061
[TBL] [Abstract][Full Text] [Related]
19. Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
Crozet C; Lezmi S; Flamant F; Samarut J; Baron T; Bencsik A
J Infect Dis; 2007 Apr; 195(7):997-1006. PubMed ID: 17330790
[TBL] [Abstract][Full Text] [Related]
20. Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation.
Murayama Y; Yoshioka M; Horii H; Takata M; Yokoyama T; Sudo T; Sato K; Shinagawa M; Mohri S
Biochem Biophys Res Commun; 2006 Sep; 348(2):758-62. PubMed ID: 16890914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
